Abstract:Organic anion transporters (OATs) and organic anion-transporting polypeptides (OATPs), encoded by a number of solute carrier (SLC)22A and SLC organic anion (SLCO) genes, mediate the absorption and distribution of drugs and other xenobiotics. The regulation of OATs and OATPs is complex, comprising both transcriptional and post-translational mechanisms. Plasma membrane expression is required for cellular substrate influx by OATs/OATPs. Thus, interest in post-translational regulatory processes, including membrane targeting, endocytosis, recycling and degradation of transporter proteins, is increasing because these are critical for plasma membrane expression. After being synthesized, transporters undergo N-glycosylation in the endoplasmic reticulum and Golgi apparatus and are delivered to the plasma membrane by vesicular transport. Their expression at the cell surface is maintained by de novo synthesis and recycling, which occurs after clathrin- and/or caveolin-dependent endocytosis of existing protein. Several studies have shown that phosphorylation by signalling kinases is important for the internalization and recycling processes, although the transporter protein does not appear to be directly phosphorylated. After internalization, transporters that are targeted for degradation undergo ubiquitination, most likely on intracellular loop residues. Epigenetic mechanisms, including methylation of gene regulatory regions and transcription from alternate promoters, are also significant in the regulation of certain SLC22A/SLCO genes. The membrane expression of OATs/OATPs is dysregulated in disease, which affects drug efficacy and detoxification. Several transporters are expressed in the cytoplasmic subcompartment in disease states, which suggests that membrane targeting/internalization/recycling may be impaired. This article focuses on recent developments in OAT and OATP regulation, their dysregulation in disease and the significance for drug therapy.

The role of organic anion transporting polypeptides in drug absorption, distribution, excretion and drug-drug interactions

Pharmacokinetics roles of organic anion transporting polypeptides

Genetic Polymorphisms and Function of the Organic Anion-Transporting Polypeptide 1A2 and Its Clinical Relevance in Drug Disposition

Xenobiotic Transporters of the Human Organic Anion Transporting Polypeptides (OATP) Family

Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family.

Advances in Drug-drug Interactions Mediated by Organic Anion Trans-porting Polypeptides

The involvement of human organic anion transporting polypeptides (OATPs) in drug-herb/food interactions

Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination

Role of organic cation transporters in drug–drug interaction

Trafficking and other regulatory mechanisms for organic anion transporting polypeptides and organic anion transporters that modulate cellular drug and xenobiotic influx and that are dysregulated in disease

Genetic Polymorphisms of Human Hepatic OATPs: Functional Consequences and Effect on Drug Pharmacokinetics

Advances in investigations of gene polymorphisms and drug-drug interactions mediated by organic anion transporting polypeptides OATP1B1 and OATP1B3

Effect on drug transport of OATP1A2

Research Advances in Organic Anion Transporter

Organic Anion Transporters and Their Implications in Pharmacotherapy

Drug transport by Organic Anion Transporters (OATs)

In Vivo Regulation of Small Molecule Natural Products, Antioxidants, and Nutrients by OAT1 and OAT3

Progress on Interactions Mediated by Organic Anion Transporting Polypeptides Between Herbs and Chemical Medicines

Research status of organic anion transport polypeptide 1B1 in transcription and protein expression regulation mechanism

Progress in the interaction between the organ anion transport protein OAT1,OAT3 and drugs metabolism

Progress on drug -drug interactions among oral antidiabetic drugs mediated by organic anion transporting polypeptides